Skip to main content

Table 2 Target-to-background ratio of the SUVs and SULs of metastatic lesions in baseline 18F-FDG-PET and 18F-FLT-PET

From: Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer

Metastatic site

Units

Bone

Lung

Liver

Other

18F-FDG-PET

SUVs

5.94 ± 4.35

10.81 ± 15.32

3.77 ± 2.57

17.39 ± 21.05

SULs

6.01 ± 4.40

9.22 ± 10.44

2.76 ± 1.85

11.91 ± 9.43

18F-FLT-PET

SUVs

1.90 ± 1.91

5.81 ± 4.09

1.00 ± 0.42

10.38 ± 8.23

SULs

2.70 ± 2.67

4.96 ± 2.68

1.04 ± 0.27

7.40 ± 5.56